Total Voting Rights

Guildford, UK - 1 March 2022: In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), Ergomed plc (the "Company") announces the following information.

The Company's issued share capital as at 28 February 2022 consisted of 49,288,071 ordinary shares of 1p each, none of which were held in treasury.  Each ordinary share in the capital of the Company carries one voting right.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the DTRs.

ENDS

Enquiries:

Ergomed plc                                                                                  Tel: +44 (0) 1483 402 975

Dr Miroslav Reljanović (Executive Chairman)      

Richard Barfield (Chief Financial Officer)           

Keith Byrne (Senior Vice-President, Capital Markets & Strategy)

Numis                                                                                             Tel: +44 (0) 20 7260 1000

Freddie Barnfield / Euan Brown (Nominated Adviser)      

James Black (Broker)   

Peel Hunt LLP                                                                                Tel: +44 (0) 20 7418 8900

James Steel / Dr Christopher Golden

Consilium Strategic Communications                                        Tel: +44 (0) 20 3709 5700

Chris Gardner / Matthew Neal                                                        ergomed@consilium-comms.com

Angela Gray

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO). For further information, visit: http://ergomedplc.com.